Objective: To describe varicose vein as a cause of obstruction of the teat cistern in dairy cattle and to report therapeutic options and outcome.
Study Design: Retrospective case series.
Animals: Dairy cows (n = 22).
Methods: Medical records (1998-2011) of dairy cows admitted for milking difficulties caused by a teat varicose vein were reviewed. Three treatment approaches were used: sclerotherapy, ligation of the vein associated with sclerotherapy, and phlebectomy. Long-term outcome was obtained ≥ 6 months after treatment and defined as a milking improvement. Descriptive statistics were used to determine the population at risk and a chi square test was used to evaluate the relationship between treatments and outcomes.
Results: Twenty-four teats (22 cows) had a varicose vein. Forequarters were more frequently affected than rear quarters (P < .01). Three sclerotherapies, 12 ligations associated with sclerotherapy and 6 phlebectomies were performed. Five veins were not treated. Overall prognosis with treatment was good (84%) at ≥ 6 months and was not significantly different between treatment types (P = .38). Recurrence of the obstruction by the varicose vein occurred in 3 of 19 teats.
Conclusions And Clinical Relevance: Several surgical options are available for treatment of teat varicose veins. The overall prognosis of return to normal milking is good.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1532-950X.2013.12062.x | DOI Listing |
Ann Vasc Surg
January 2025
The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China. Electronic address:
Background: Varicose veins (VVs) are a common chronic venous disorder with a complex pathophysiology involving immune dysregulation, inflammation, and genetic predisposition. This study aims to identify immune-related causal factors in the pathogenesis of VVs using Mendelian randomization (MR).
Methods: A two-sample MR analysis was conducted to assess the causal relationships between immune cell phenotypes and VVs.
Phlebology
January 2025
Department of Vascular Surgery, University Hospital Leipzig, Leipzig, Germany.
Aim: This study aimed to develop a web-based machine learning (ML) model to predict the lifetime likelihood of developing varicose veins using global disease prevalence data.
Methods: We utilized data from a systematic review, registered under PROSPERO (CRD42021279513), which included 81 studies on varicose vein prevalence across various geographic regions. The data used to build the ML model included disease prevalence as the outcome (%), along with the following predictors: mean age, gender distribution (%), mean body mass index (BMI) of the study cohort, and the mean gravity field of the study region (mGal), representing variations in Earth's underground mass distribution that influence blood and fluid redistribution in the human body, affecting disease prevalence.
PLoS One
January 2025
CNPQ (Researcher PQ1D), Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil.
Our objective was to assess the effect of Venous Leg Ulcer (VLU) healing on Quality of Life (QoL) in patients undergoing compression therapy. This non-randomized, quasi-experimental, and observational study involved patients with VLU. A convenience sample of individuals receiving services was followed for at least one year while undergoing compression therapy.
View Article and Find Full Text PDFAnn Vasc Dis
January 2025
Department of Cardiovascular Surgery, Shiga University of Medical Science, Otsu, Shiga, Japan.
Endovenous surgery in the treatment of varicose veins generally consists of laser or radiofrequency ablation (RFA) as endovenous thermal ablation (ETA) with a phlebectomy or foam sclerotherapy of tributary varicose veins to improve symptomatic or cosmetic problems. Nevertheless, the efficacy of their concomitant treatments is still controversial for a decade. In the guidelines of the Japanese Society of Phlebology, concomitant phlebectomy of tributary varicose veins with ETA is described that it is not recommended officially.
View Article and Find Full Text PDFInt Angiol
December 2024
Vascular Surgery Research Laboratories, Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA -
The glycocalyx is an essential structural and functional component of endothelial cells. Extensive hemodynamic changes cause endothelial glycocalyx disruption and vascular dysfunction, leading to multiple arterial and venous disorders. Chronic venous disease (CVD) is a common disorder of the lower extremities with major health and socio-economic implications, but complex pathophysiology.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!